Royal UNIBREW A/S COMPANY ANNOUNCEMENT NO 13/2024 - May 1, 2024 On Tuesday, 30 April 2024 at 4 pm CEST Royal Unibrew A/S held its Annual General Meeting at which the below resolutions were adopted. Agenda and full contents of the proposals: 1. Report on the Company’s business activities during the year The Board of Directors’ report was noted. 2. Presentation of the audited Annual Report for 2023 for approval The Company’s Annual Report for 2023 was adopted by the Annual General Meeting. 3. Resolution to discharge the Board of Directors and the Executive Management from liability The General Meeting adopted the resolution to discharge the Board of Directors and the Executive Board from liability in relation to the approved Annual Report 2023. 4. Proposed distribution of profit for the year, including resolution on the amount of dividend The General Meeting adopted the Board of Directors’ proposal that no ordinary dividend is paid out and that the net profit of DKK 1,095 million is to be carried forward. 5. Presentation of the Remuneration Report for 2023 for approval The Company’s Remuneration Report for 2023 was approved by the Annual General Meeting. 6. Approval of remuneration of the Board of Directors for 2024 The General Meeting adopted the Board of Directors’ proposal regarding the fees to the Board of Directors for 2024 remain unchanged. The base fee will thus be DKK 415,000 per board member (“Base Fee”). The Chair shall continue to receive three times the Base Fee (including Base Fee) and the Deputy Chair shall continue to receive 1¾ times the Base Fee (including Base Fee) for their extended duties and obligations. Board members who also serve on the Nomination and Remuneration Committee or the Audit Committee will receive an additional annual fixed fee corresponding to 33% of the Base Fee per membership of one of the board committees, and the Chairs of the committees receive an annual fixed fee corresponding to 50% of the Base Fee per chairmanship for their extended duties and obligations. In addition to the above stated remuneration to members of the Board of Directors, the Company pays out-of-pocket expenses, including travel and transportation costs, associated with the services rendered as member of the Board of Directors, and the Company may also pay foreign social charges and similar charges within the EU, charged by foreign authorities in relation to the fees. 7. Consideration of proposals submitted by the Board of Directors 7.1 Authorisation to acquire treasury shares The General Meeting adopted the Board of Directors proposal to authorize the Board of Directors until next Annual General Meeting to let the Company acquire treasury shares equivalent to a total of 10% of the Company’s share capital at the time of the authorization, provided that the Company’s total holding of treasury shares at no point exceeds 10% of the Company’s share capital. The consideration must not deviate by more than 10% from the official price quoted at Nasdaq Copenhagen at the time of acquisition. 7.2 Authorization to distribute extraordinary dividend The General Meeting adopted the Board of Directors proposal to distribute extraordinary dividend of up to DKK 14.5 per share (of a nominal value of DKK 2) to the shareholders of the Company, cf. section 182(2) of the Danish Companies Act. The authorization shall be in force until the next annual general meeting of the Company. 8. Election of members of the Board of Directors The General Meeting re-elected: o Peter Ruzicka o Jais Valeur o Catharina Stackelberg-Hammarén o Heidi Kleinbach-Sauter o Torben Carlsen The General Meeting elected new board member: o Lise Mortensen 9. Appointment of state-authorised public auditor The General Meeting adopted the Board of Directors proposal to elect Deloitte as the Company’s auditor. The appointment applies to both the financial auditing as well as assurance engagements relating to sustainability reporting. ******** Following the Annual General Meeting, the Board of Directors elected: o Peter Ruzicka as Chair and o Jais Valeur as Deputy Chair Board composition following the Annual General Meeting: o Peter Ruzicka (Chair) o Jais Valeur (Deputy Chair) o Catharina Stackelberg-Hammarén o Heidi Kleinbach-Sauter o Torben Carlsen o Lise Mortensen o Kenn Hvarre (employee representative) o Claus Kærgaard (employee representative) o Michael Nielsen (employee representative) Nomination and Remuneration Committee: o Peter Ruzicka (Chair) o Jais Valeur Audit Committee: o Lise Mortensen (Chair) o Peter Ruzicka Yours sincerely Royal Unibrew A/S The Board of Directors Attachment Fond-RU-13-2024-uk - Annual General Meeting
Annual General Meeting 2024
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...